These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8545320)

  • 1. [Biclonal gammapathy in type I Gaucher disease].
    Kaminsky P; Klein M; Jacob C; Deibener J; Duc M
    Presse Med; 1995 Oct; 24(30):1400. PubMed ID: 8545320
    [No Abstract]   [Full Text] [Related]  

  • 2. Malignancies and monoclonal gammopathy in Gaucher disease; a systematic review of the literature.
    Arends M; van Dussen L; Biegstraaten M; Hollak CE
    Br J Haematol; 2013 Jun; 161(6):832-42. PubMed ID: 23594419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gaucher's disease associated with monoclonal gammapathy of undetermined significance: a case report.
    Airò R; Gabusi G; Guindani M
    Haematologica; 1993; 78(2):129-31. PubMed ID: 8349190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gaucher's disease and benign monoclonal gammapathy. A case report with immunofluorescence study of bone marrow and spleen.
    Turesson I; Rausing A
    Acta Med Scand; 1975 Jun; 197(6):507-12. PubMed ID: 1155227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gaucher disease and monoclonal gammopathy: a report of 17 cases and impact of therapy.
    Grosbois B; Rose C; Noël E; Serratrice Cde R; Dobbelaere D; Gressin V; Chérin P; Hartmann A; Javier RM; Clerson P; Hachulla E; Jaussaud R;
    Blood Cells Mol Dis; 2009; 43(1):138-9. PubMed ID: 19427246
    [No Abstract]   [Full Text] [Related]  

  • 6. Type I Gaucher disease with severe skeletal destruction, extraosseous extension, and monoclonal gammopathy.
    Kaloterakis A; Cholongitas E; Pantelis E; Papadimitriou C; Durakis S; Filiotou A
    Am J Hematol; 2004 Dec; 77(4):377-80. PubMed ID: 15551278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hyper-ferritinemia and Gaucher disease].
    Laine F; Guyader D; Turlin B; Moirand R; Deugnier Y; Brissot P
    Gastroenterol Clin Biol; 1996; 20(5):512-3. PubMed ID: 8761155
    [No Abstract]   [Full Text] [Related]  

  • 8. [Gaucher's disease with paraproteinemia].
    Fajstauer J; Mazák J; Kerekes Z
    Vnitr Lek; 1987 Mar; 33(3):279-82. PubMed ID: 3660684
    [No Abstract]   [Full Text] [Related]  

  • 9. Pseudo-Gaucher plasma cells in the bone marrow of a patient with monoclonal gammopathy of undetermined significance.
    Regazzoli A; Pozzi A; Rossi G
    Haematologica; 1997; 82(6):727. PubMed ID: 9499677
    [No Abstract]   [Full Text] [Related]  

  • 10. Potential biomarkers of osteonecrosis in Gaucher disease.
    Pavlova EV; Deegan PB; Tindall J; McFarlane I; Mehta A; Hughes D; Wraith JE; Cox TM
    Blood Cells Mol Dis; 2011 Jan; 46(1):27-33. PubMed ID: 21075651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Capillary leak syndrome in the course of Gaucher disease: the result of monoclonal gammopathy?].
    Nicolas X; Tilly Gentric A; Cholet F; Hiar I; Pennec YL; Garré M
    Rev Med Interne; 2000 Dec; 21(12):1128-9. PubMed ID: 11191681
    [No Abstract]   [Full Text] [Related]  

  • 12. Hematologic manifestations and leukemia in Gaucher's disease.
    Ranade A; Chintapatla R; Varma M; Sandhu G
    Clin Adv Hematol Oncol; 2013 Apr; 11(4):253-5. PubMed ID: 23604244
    [No Abstract]   [Full Text] [Related]  

  • 13. CCL18 as an alternative marker in Gaucher and Niemann-Pick disease with chitotriosidase deficiency.
    Chang KL; Hwu WL; Yeh HY; Lee NC; Chien YH
    Blood Cells Mol Dis; 2010 Jan; 44(1):38-40. PubMed ID: 19819171
    [No Abstract]   [Full Text] [Related]  

  • 14. Biochemical markers of bone turnover as tools in the evaluation of skeletal involvement in patients with type 1 Gaucher disease.
    Drugan C; Jebeleanu G; Grigorescu-Sido P; Caillaud C; Craciun AM
    Blood Cells Mol Dis; 2002; 28(1):13-20. PubMed ID: 11814307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of multiple myeloma in patients with Gaucher disease.
    Machaczka M; Lerner R; Klimkowska M; Hägglund H
    Am J Hematol; 2009 Oct; 84(10):694-6. PubMed ID: 19743447
    [No Abstract]   [Full Text] [Related]  

  • 16. Screening for Gaucher disease among patients with plasma cell dyscrasias.
    Ntanasis-Stathopoulos I; Gavriatopoulou M; Fotiou D; Kanellias N; Migkou M; Eleutherakis-Papaiakovou E; Kastritis E; Dimopoulos MA; Terpos E
    Leuk Lymphoma; 2021 Mar; 62(3):761-763. PubMed ID: 31566473
    [No Abstract]   [Full Text] [Related]  

  • 17. The cytokine and chemokine profiles in rhabdomyolysis in a patient with Gaucher disease type II.
    Wakusawa K; Haginoya K; Ishitobi M; Hino-Fukuyo N; Togashi N; Sato I; Ohura T; Yokoyama H; Kikuchi M; Iinuma K; Tsuchiya S
    Neuropediatrics; 2010 Feb; 41(1):39-42. PubMed ID: 20571990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloidosis. An unusual complication of Gaucher's disease.
    Dikman SH; Goldstein M; Kahn T; Leo MA; Weinreb N
    Arch Pathol Lab Med; 1978 Sep; 102(9):460-2. PubMed ID: 581149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D-dimer assay in Gaucher disease: correlation with severity of bone and lung involvement.
    Shitrit D; Rudensky B; Zimran A; Elstein D
    Am J Hematol; 2003 Aug; 73(4):236-9. PubMed ID: 12879425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coagulation abnormalities in type 1 Gaucher disease in children.
    Deghady A; Marzouk I; El-Shayeb A; Wali Y
    Pediatr Hematol Oncol; 2006; 23(5):411-7. PubMed ID: 16728361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.